RFLP£¨Restriction Fragment Length Polymorphism, RFLP£©ÏÞÖÆÐÔƬ¶Î³¤¶È¶à̬ÐÔ£¬µ±ÓÃÏÞÖÆÐÔÄÚÇÐøÇиͬƷÖÖ»ò¸öÌåµÄ»ùÒò×éDNAʱ£¬Èç¹ûÏÞÖÆÐÔÄÚÇÐøµÄøÇÐλµãµÄ¼î»ù·¢ÉúÍ»±ä£¬»òÕßøÇÐλµãÖ®¼äDNAƬ¶Î·¢Éú¼î»ùµÄ²åÈë»òȱʧ£¬µ¼ÖÂøÇÐƬ¶ÏµÄ´óС¡¢ÊýÁ¿·¢ÉúÁ˱仯£¬²úÉúÏ൱¶àµÄÊýÄ¿ºÍ´óС²»µÈµÄDNAƬ¶Î¡£ÕâÖֱ仯¿ÉÒÔͨ¹ýÌض¨µÄ̽ÕëÔÓ½»½øÐмì²â£¬´Ó¶ø¿ÉÒԱȽϲ»Í¬Æ·ÖÖ»ò¸öÌåÖ®¼äµÄDNAˮƽµÄ²îÒ죨»ò¶à̬ÐÔ£©¡£¹ã·ºÓÃÓÚ»ùÒò×éÒÅ´«Í¼Æ×¹¹½¨¡¢»ùÒò¶¨Î»ÒÔ¼°ÉúÎïµÄ½ø»¯ºÍ·ÖÀà¹ØϵÑо¿¡£ |1H9,:*%
kz}Bc
F
RAPD£¨Random Amplified Polymorphism DNA, RAPD£©Ëæ»úÀ©Ôö¶à̬ÐÔDNA£¬ÀûÓÃËæ¼´ÒýÎïÀ©ÔöÑ°ÕÒ¶à̬ÐÔDNAƬ¶ÎµÄ·Ö×Ó±ê¼Ç·½·¨¡£Êǽ¨Á¢ÔÚPCR¼¼Êõ»ù´¡ÉÏ£¬ÀûÓÃһϵÁУ¨Í¨³£Êý°Ù£©²»Í¬µÄËæ»úÅÅÁмî»ù˳ÐòµÄ¹Ñ¾ÛºËÜÕËáµ¥Á´£¨Ò»°ãΪ10 bp£©ÎªÒýÎ¶ÔËùÑо¿µÄ»ùÒò×éDNA½øÐÐPCRÀ©Ôö£¬È»ºóÓÃÄý½ºµçÓ¾·Ö¿ªÀ©ÔöƬ¶Î£¬EBµÈȾɫ¼ÁȾɫºó¼ì²âÀ©Ôö²úÎïDNAƬ¶ÎµÄ¶à̬ÐÔ¡£ÓëRAPD¼¼ÊõÏàÀàËƵĻ¹ÓÐAP-PCR£¨Arbitrary Primed PCR£©ºÍDAF£¨DNA Amplified Fingerprints£©2ÖÖ±ê¼Ç¼¼Êõ¡£ÔÚAP-PCR·ÖÎöÖУ¬ËùʹÓõÄÒýÎï½Ï³¤£¨Í¨³£10¡«50 bp£©£¬À©Ôö·ÖΪ3¸ö²¿·Ö£¬Ã¿¸ö²¿·ÖÒªÇóµÄÌõ¼þºÍ×é·ÖµÄŨ¶È´æÔÚ²îÒì¡£DAFÊÇÒ»ÖָĽøµÄRAPD·ÖÎö¼¼Êõ£¬ÓëRAPD¼¼Êõ²»Í¬µÄÊÇËüʹÓÃÒýÎïŨ¶È¸ü¸ß£¬³¤¶È¸ü¶Ì£¨Ò»°ã5¡«8 bp£©£¬Ö»ÓÐ2¸öζÈÑ»·£¬²¢³£Óþ۱ûÏ©õ£°·Äý½ºµçÓ¾£¬ËùÌṩÆ×´øÐÅÏ¢±ÈRAPD´óµÃ¶à¡£ /m>SEo\{C
6qmV/DL
AFLP£¨Amplified fragment length polymorphism£¬AFLP£© À©ÔöƬ¶Î³¤¶È¶à̬ÐÔ£¬AFLPÊÇRFLPºÍPCR½áºÏµÄ²úÎÆä»ù±¾ÔÀíÊÇ£º½«»ùÒò×éDNA½øÐÐÏÞÖÆÐÔÄÚÇÐøøÇУ¬È»ºóÑ¡ÔñÌض¨µÄƬ¶Î½øÐÐPCRÀ©Ôö£¬Ê¹ÓÃË«Á´È˹¤"½ÓÍ·"Óë»ùÒò×éDNAµÄøÇÐƬ¶ÎÏàÁ¬½Ó×÷ΪÀ©Ôö·´Ó¦Ä£°å£¬"½ÓÍ·"Óë"½ÓÍ·"ÏàÁÚµÄøÇÐƬ¶ÎµÄ¼¸¸ö¼î»ùÐòÁÐ×÷ΪÒýÎïµÄ½áºÏλµã¡£ÕâÑù¾ÍÖ»ÓÐÄÇЩÁ½¶ËÐòÁÐÄÜÓëÑ¡Ôñ¼î»ùÅä¶ÔµÄÏÞÖÆÐÔƬ¶Î±»À©Ôö£¬ÔÙÔڸ߷ֱæÁ¦µÄ²âÐò½ºÉÏ·Ö¿ªÕâЩÀ©Ôö²úÎï¡£¸Ã¼¼ÊõµÄ¶ÀÌØÖ®´¦ÔÚÓÚËùÓõÄרÓÃÒýÎï¿ÉÔÚ²»ÖªµÀDNAÐÅÏ¢µÄÇ°ÌáϾͿɶÔøÇÐƬ¶Î½øÐÐPCRÀ©Ôö¡£ÊÇÄ¿Ç°Ò»ÖÖÊ®·ÖÀíÏëÓÐЧµÄ·Ö×Ó±ê¼Ç /T {R\
^-Arfm%dn
STS£¨Sequence-Tagged Site, STS£©ÐòÁбêǩλµã ÊÇ»ùÒò×éÉ϶¨Î»Ã÷È·¡¢×÷Ϊ½ç±ê²¢ÄÜͨ¹ýPCRÀ©Ôö±»Î¨Ò»²Ù×÷µÄ¶ÌµÄ¡¢µ¥¿½±´DNA ÐòÁУ¬£¬ÓÃÓÚ²úÉú×÷ͼλµã£¬¼´²â¶¨Ò»ÏµÁÐSTS µÄ´ÎÐò¼´¿É×÷³ö»ùÒò×éÇøÓòµÄͼÆס£STSÖ÷Òª°üÀ¨¼òµ¥Öظ´ÐòÁУ¨Simple Sequence Repeat Polymorphisms, ¼ò³ÆSSR»òSSRP£©¡¢Ãª¶¨¼òµ¥Öظ´ÐòÁУ¨ Anchored Simple Sequence Repeats, ASSR£©¡¢ÐòÁÐÌØÒìÀ©ÔöÇøÓò£¨Sequence-characterized amplified regions£©¡¢Ã¸ÇÐÀ©Ôö¶à̬ÐÔÐòÁУ¨Cleaved Amplified Polymorphism Sequences, CAPS£©¡¢µ¥ÒýÎïÀ©Ôö·´Ó¦£¨Single Primer Amplification Reaction, SPAR£©µÈ±ê¼Ç¼¼Êõ¡£ +8"8s
si~zg\uY
SSR (Simple¡¡Sequence¡¡Repeats£¬SSR) ¼òµ¥Öظ´ÐòÁÐ ÕæºËÉúÎïµÄ»ùÒò×éÖÐÉ¢²¼´óÁ¿µÄ´®ÁªÖظ´ÐòÁУ¬ÆäÖÐ2¡«4¸öbpµÄ΢ÎÀÐÇÐòÁоßÓи߶ȶà̬ÐÔ£¬Î¢ÎÀÐÇÔڽṹÉϵÄ×î´óÌصãÊÇÁ½¶ËÐòÁнϱ£ÊØ£¬Òò´Ë¿ÉÉè¼ÆÓëÁ½¶Ë±£ÊØÐòÁл¥²¹µÄÒýÎï½øÐÐPCEÀ©Ôö£¬À´½Òʾ΢ÎÀÐǵĶà̬ÐÔ¡£SSR ÊǼì²â¶à̬ÐÔµÄÒ»ÖÖÓÐЧ·½·¨¡£ % &H^UxC
1NZpd'$c
SSCP£¨Single Strand Conformation Polymorphism, SSCP£©µ¥Á´¹¹Ïñ¶à̬ÐÔ ÊÇÖ¸Ïàͬ³¤¶ÈµÄµ¥Á´DNAÒòºËÜÕËáÐòÁеIJîÒ죬ÉõÖÁµ¥¸ö¼î»ù²»Í¬£¬¶ø²úÉúµÄ¹¹Ïñ±äÒ죬ÔڷDZäÐÔ¾Û±ûÏ©õ£°·ÖбíÏÖΪµçӾǨÒÆÂʵIJî±ð¡£PCR²úÎï±äÐÔ´¦Àí£¬Ë«Á´DNA·Ö¿ª³Éµ¥Á´£¬ÔÙÓ÷DZäÐÔ¾Û±ûÏ©õ£°·Äý½ºµçÓ¾·ÖÀ룬¸ù¾ÝÌõ´øλÖñ仯À´ÅжÏÄ¿µÄƬ¶ÎÖÐÊÇ·ñ´æÔÚÍ»±ä¡£SSCP·ÖÎö¶ÔDNAÐòÁеĸıä·Ç³£Ãô¸Ð£¬³£³£Ò»¸ö¼î»ù²î±ð¶¼ÄÜÏÔʾ³öÀ´¡£SSCP½á¹ûÅж¨ÊÇͨ¹ý¶à¸öÑùÆ·Ö®¼ä¶Ô±È£¬¹Û²ìÌõ´øÖ®¼äλÖøı䣬´Ó¶øÏÔʾ³ö²»Í¬ÉúÎï¸öÌåµÄDNAÌØÒìÐÔ£¬´ïµ½Ö¸ÎÆ·ÖÎöµÄÄ¿µÄ¡£¸Ã¼¼ÊõÒѱ»¹ã·ºÓÃÓÚ°©»ùÒòºÍ¿¹°©»ùÒò±äÒìµÄ¼ì²â¡¢ÒÅ´«²¡µÄÖ²¡»ùÒò·ÖÎöÒÔ¼°»ùÒòÕï¶Ï¡¢»ùÒòÖÆͼµÈÁìÓò¡£ _7u&.l<;
bUy!hS;s
SNP£¨Single Nucleotide Polymorphism, SNP£©µ¥ºËÜÕËá¶à̬ÐÔ ÊÇÖ¸DNAÐòÁÐÉϵ¥¸öºËÜÕËáµÄ²îÒ죬Êǵ¥¸öºËÜÕËáÖû»²úÉúµÄÒÅ´«±ê¼Ç¡£¸ù¾Ý´ÓSTSÖÐÈ·¶¨SNPλµãµÄ¾Ñ飬ÿǧ¸öºËÜÕËá»á³öÏÖÒ»¸ö±ê¼Çλµã£¬ÒòSNPµÄ·Ö²¼Ãܼ¯¡£¼ì²âSNPµÄ×î¼Ñ·½·¨ÊÇDNAоƬ¼¼Êõ£¬Èç¹ûÄܽ«ËùÓÐSNPÈ«²¿ÐÅÏ¢ÔØÈëDNAоƬ£¬¾Í¿ÉÖÆÔì»ùÒò×éɨÃèÒÇ£¬ÓÃÀ´É¨Ãè¸÷¸ö¸öÌå²¢·ÖÎöËüÃÇÔÚ»ùÒò×é³ÉÉϵIJîÒì¡£ H_S"4ISS_
RWu<
dY#ym
SCAR(Sequence-characterized amplified regions) SCAR±ê¼ÇÊÇÔÚRAPD¼¼ÊõµÄ»ù´¡ÉÏ·¢Õ¹ÆðÀ´µÄ¡£Ä¿±êRAPDƬ¶Î¿Ë¡ºÍ²âÐò£¬¸ù¾ÝÔRAPDƬ¶ÎÁ½Ä©¶ËµÄÐòÁÐÉè¼ÆÌض¨ÒýÎï½øÐÐPCRÌØÒìÀ©Ôö¡£ Z= -fL
hxJKYU^%m
EST£¨expressed sequence tag£¬EST£©±í´ïÐòÁбêÇ© ¶ÌµÄ¡¢µ¥´Î£¨²âÐò£©ÔĶÁµÄcDNA 5¡¯»ò3¡®¶ËÐòÁС£Ò²°üÀ¨À´×ÔÓÚ²îÒìÏÔʾºÍRACEʵÑéµÄcDNAÐòÁС£Ò»°ãÊÇÀ´×Ô²»Í¬×éÖ¯À´Ô´µÄcDNAÐòÁУ¬³¤¶ÈÔÚ300-500bp×óÓÒ¡£ 9X
1vL
h7.jWJTo
Contig ÖصþȺ»òÁÚ½ÓƬ¶Î »ùÒò×é²âÐòÖн«Ðí¶àÐòÁÐƬ¶Î¾¹ý±È¶ÔÕÒµ½ÖصþÇø£¬´Ó¶øÁ¬½Ó³É³¤Æ¬¶Î£¬ÕâЩƬ¶Ï³ÆÖصþÁ¬ÐøȺ£¬¼ò³ÆÖصþȺ¡£ m=COF$<
0S+$l
UniGene ¡ª ±»ÕûÀí³É´ØµÄESTºÍÈ«³¤mRNAÐòÁУ¬Ã¿Ò»¸ö´ú±íÒ»ÖÖÌض¨ÒÑÖªµÄ»ò¼ÙÉèµÄÈËÀà»ùÒò£¬Óж¨Î»Í¼ºÍ±í´ïÐÅÏ¢ÒÔ¼°Í¬ÆäËü×ÊÔ´µÄ½»²æ²Î¿¼¡£ &\5bo=5V
U4Y)Jk
SAGE£¨serial analysis of gene expression,£©£¬»ùÒò±í´ïϵÁзÖÎö Êǽü¼¸ÄêÀ´·¢Õ¹ÆðÀ´µÄÒ»ÖÖ¿ìËÙ·ÖÎö»ùÒò±í´ïˮƽÐÅÏ¢µÄ¼¼Êõ¡£Ëüͨ¹ý¿ìËÙºÍÏêϸ·ÖÎö³ÉǧÉÏÍò¸öESTÀ´Ñ°ÕÒ³ö±í´ï·á¶È²»Í¬µÄSAGE±êÇ©ÐòÁУ¬´Ó¶ø½Ó½üÍêÕûµØ»ñµÃ»ùÒò×éµÄ±í´ïÐÅÏ¢¡£ dKXzFyW
? YIe<
»ùÒò×éѧ£*****enomics£©£¬Ö¸¶ÔËùÓлùÒò½øÐлùÒò×é×÷ͼ£¨°üÀ¨ÒÅ´«Í¼Æס¢ÎïÀíͼÆס¢×ªÂ¼±¾Í¼Æ×£©£¬ºËÜÕËáÐòÁзÖÎö£¬»ùÒò¶¨Î»ºÍ»ùÒò¹¦ÄÜ·ÖÎöµÄÒ»ÃÅ¿Æѧ¡£»ùÒò×éÑо¿Ó¦¸Ã°üÀ¨Á½·½ÃæµÄÄÚÈÝ£ºÒÔÈ«»ùÒò×é²âÐòΪĿ±êµÄ½á¹¹»ùÒò×éѧºÍÒÔ»ùÒò¹¦Äܼø¶¨ÎªÄ¿±êµÄ¹¦ÄÜ»ùÒò×éѧ£¬ÓÖ±»³ÆΪºó»ùÒò×飨postgenome£©Ñо¿¡£ 6W]C`
Kx[+$Qt
µ°°×ÖÊ×飨proteome£©Ö¸È«²¿»ùÒò±í´ïµÄÈ«²¿µ°°×Öʼ°Æä´æÔÚ·½Ê½£¬ÊÇÒ»¸ö»ùÒò¡¢Ò»¸öϸ°û»ò×éÖ¯Ëù±í´ïµÄÈ«²¿µ°°×Öʳɷ֣¬µ°°×ÖÊ×éѧÊDz»Í¬Ê±¼äºÍ¿Õ¼ä·¢»Ó¹¦ÄܵÄÌض¨µ°°×ÖÊȺÌåµÄÑо¿¡£ #@V<{/;49
Z3Ww@&bU